As of February 2020, at least 20 manufacturers had received FDA approval to manufacture generic versions of rosuvastatin calcium
For details on these savings offers for CRESTOR and to find out if you are eligible Now, if Crestor follows the usual patent-cliff trajectory, the brand will quickly tank, leaving AstraZeneca billions of dollars in the hole
Many generic versions of rosuvastatin tablets have since been approved
The Allergan generics unit is set to join Teva Pharmaceutical Industries under a $20 By Andrew Williams-- Late last year, in AstraZeneca v
2 and include the sales of Crestor by AstraZeneca, the sales of Crestor by Shionogi, and the patent royalties earned by Shionogi from the AstraZeneca sales of Crestor
Patient out-of-pocket expenses may vary
Rosuvastatin is a synthetic statin-type HMG-CoA reductase inhibitor developed by AstraZeneca
05 billion U
Area Agencies on Aging (ElderCare) Local area agencies on aging may be able to help patients age 65 years and older who cannot afford their medicines
Sales of Crestor are forecast to rise to $6